GlassScriptPhysician profile
Jamie M Tatar
NPI 1871773846
$1,070.20
in general payments reported to CMS, 2019-2025
8 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $94.87 · 2023: $121 · 2024: $535 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932 · Education: $42.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.34 |
| Education | $42.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $396.70 | 2022-2024 | Sotyktu |
| Ucb, INC. | $257.96 | 2024-2025 | Bimzelx |
| Dermavant Sciences, INC. | $180.76 | 2023-2024 | Vtama |
| Organon LLC | $92.15 | 2025 | Vtama |
| Janssen Biotech, INC. | $57.80 | 2024 | Tremfya |
| Abbvie INC. | $48.50 | 2025 | |
| Lilly USA, LLC | $18.35 | 2024 | Olumiant, Taltz |
| Galderma Laboratories, L.P. | $17.98 | 2025 | Nemluvio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jamie Tatar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.